FC1138497

Download as pdf or txt
Download as pdf or txt
You are on page 1of 5

Lab No. : COC/12-02-2024/SR8737031 Lab Add.

: Newtown,Kolkata-700156

Patient Name : LAXMI HEMBRAM Ref Dr. : Dr.Dr Anirban Dey

Age : 62 Y 0 M 0 D Collection Date : 12/Feb/2024 03:08PM

Gender :F Report Date : 12/Feb/2024 05:51PM

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Bio Ref. Interval Unit

CREATININE, BLOOD , GEL SERUM 1.41 0.5-1.1 mg/dL


(Method:Jaffe, alkaline picrate, kinetic)

Suggested follow up

Correlate clinically

LIPID PROFILE , GEL SERUM


CHOLESTEROL-TOTAL 203 Desirable: < 200 mg/dL mg/dL
(Method:Enzymatic) Borderline high: 200-239 mg/dL
High: > or =240 mg/dL
TRIGLYCERIDES 369 Normal:: < 150, mg/dL
(Method:GPO-Trinder) BorderlineHigh::150-199,
High:: 200-499,
VeryHigh::>500
HDL CHOLESTEROL 30 < 40 - Low mg/dl
(Method:Elimination/catalase) 40-59- Optimum
60 - High
LDL CHOLESTEROL DIRECT 136 OPTIMAL : <100 mg/dL, mg/dL
(Method:Elimination / Catalase) Near optimal/ above optimal : 100-
129 mg/dL,
Borderline high : 130-159 mg/dL,
High : 160-189 mg/dL,
Very high : >=190 mg/dL
VLDL 37 < 40 mg/dl mg/dl
(Method:Calculated)
CHOL HDL Ratio 6.8 LOW RISK 3.3-4.4 AVERAGE RISK
(Method:Calculated) 4.47-7.1 MODERATE RISK 7.1-11.0
HIGH RISK >11.0

LIPEMIC SAMPLE.

Suggested follow up

Correlate clinically

Reference: National Cholesterol Education Program. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert
Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. May 16 2001;285(19):2486-97.

*** End Of Report ***

Page 1 of 5
Lab No. : COC/12-02-2024/SR8737031 Lab Add. : Newtown,Kolkata-700156

Patient Name : LAXMI HEMBRAM Ref Dr. : Dr.Dr Anirban Dey

Age : 62 Y 0 M 0 D Collection Date : 12/Feb/2024 03:08PM

Gender :F Report Date : 12/Feb/2024 05:51PM

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Bio Ref. Interval Unit

Lab No. : COC/12-02-2024/SR8737031 Page 2 of 5


Lab No. : COC/12-02-2024/SR8737031 Lab Add. : Newtown,Kolkata-700156

Patient Name : LAXMI HEMBRAM Ref Dr. : Dr.Dr Anirban Dey

Age : 62 Y 0 M 0 D Collection Date : 12/Feb/2024 03:08PM

Gender :F Report Date : 12/Feb/2024 07:13PM

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Bio Ref. Interval Unit

TSH (THYROID STIMULATING HORMONE) 135.012 0.55-4.78 µIU/mL


(Method:CLIA)

ESTIMATED TWICE

Value at Critical alert level ,

Suggested urgent medical attention .

SUGGESTED FOLLOW-UP ESTIMATION WITH POLYETHYLENE GLYCOL (PEG) 6000 PRECIPITATION OF TSH TO RULE OUT THE
POSSIBILITY OF MACRO TSH.

Serum TSH levels exhibit a diurnal variation with the peak occurring during the night and the nadir, which approximates to 50% of the peak value, occurring
between 1000 and 1600 hours.[1,2]
References:
1. Bugalho MJ, Domingues RS, Pinto AC, Garrao A, Catarino AL, Ferreira T, Limbert E and Sobrinho L. Detection of thyroglobulin mRNA transcripts in
peripheral blood of
individuals with and without thyroid glands: evidence for thyroglobulin expression by blood cells. Eur J Endocrinol 2001;145:409-13.
2. Bellantone R, Lombardi CP, Bossola M, Ferrante A,Princi P, Boscherini M et al. Validity of thyroglobulin mRNA assay in peripheral blood of
postoperative thyroid carcinoma patients in predicting tumor recurrence varies according to the histologic type: results of a prospective study. Cancer
2001;92:2273-9.

BIOLOGICAL REFERENCE INTERVAL: [ONLY FOR PREGNANT MOTHERS]


Trimester specific TSH LEVELS during pregnancy:
FIRST TRIMESTER: 0.10 – 3.00 µ IU/mL
SECOND TRIMESTER: 0.20 -3.50 µ IU/mL
THIRD TRIMESTER : 0.30 -3.50 µ IU/mL
References:
1. Erik K. Alexander, Elizabeth N. Pearce, Gregory A. Brent, Rosalind S. Brown, Herbert Chen, Chrysoula Dosiou, William A. Grobman, Peter
Laurberg, John H. Lazarus, Susan J. Mandel, Robin P. Peeters, and Scott Sullivan.Thyroid.Mar 2017.315-389.http://doi.org/10.1089/thy.2016.0457
2. Kalra S, Agarwal S, Aggarwal R, Ranabir S. Trimester-specific thyroid-stimulating hormone: An indian perspective. Indian J Endocr Metab
2018;22:1-4.

GLUCOSE,FASTING 93 Impaired Fasting-100-125 . mg/dL


(Method:Gluc Oxidase Trinder) Diabetes- >= 126.
Fasting is defined as no caloric intake
for at least 8 hours.

In the absence of unequivocal hyperglycemia, diagnosis requires two abnormal test results from the same sample or in two separate test samples.

Reference :
ADA Standards of Medical Care in Diabetes – 2020. Diabetes Care Volume 43, Supplement 1.

Lab No. : COC/12-02-2024/SR8737031 Page 3 of 5


Lab No. : COC/12-02-2024/SR8737031 Lab Add. : Newtown,Kolkata-700156

Patient Name : LAXMI HEMBRAM Ref Dr. : Dr.Dr Anirban Dey

Age : 62 Y 0 M 0 D Collection Date : 12/Feb/2024 03:08PM

Gender :F Report Date : 12/Feb/2024 07:13PM

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Bio Ref. Interval Unit

*** End Of Report ***

Lab No. : COC/12-02-2024/SR8737031 Page 4 of 5


Lab No. : COC/12-02-2024/SR8737031 Lab Add. : Newtown,Kolkata-700156

Patient Name : LAXMI HEMBRAM Ref Dr. : Dr.Dr Anirban Dey

Age : 62 Y 0 M 0 D Collection Date : 12/Feb/2024 03:06PM

Gender :F Report Date : 12/Feb/2024 05:56PM

DEPARTMENT OF HAEMATOLOGY
Test Name Result Bio Ref. Interval Unit

HAEMOGLOBIN 9.3 12 - 15 gm/dl gm/dl


(Method:SLS haemoglobin method)

Lab No. : COC/12-02-2024/SR8737031 Page 5 of 5

You might also like